Does ENTRECTINIB Cause Disease progression? 105 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 105 reports of Disease progression have been filed in association with ENTRECTINIB (Rozlytrek). This represents 7.0% of all adverse event reports for ENTRECTINIB.
105
Reports of Disease progression with ENTRECTINIB
7.0%
of all ENTRECTINIB reports
38
Deaths
15
Hospitalizations
How Dangerous Is Disease progression From ENTRECTINIB?
Of the 105 reports, 38 (36.2%) resulted in death, 15 (14.3%) required hospitalization, and 1 (1.0%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
Yes, Disease progression is listed as a known adverse reaction in the official FDA drug label for ENTRECTINIB.
What Other Side Effects Does ENTRECTINIB Cause?
Dizziness (143)
Off label use (137)
Death (126)
Taste disorder (68)
No adverse event (65)
Constipation (60)
Fatigue (60)
Drug ineffective (58)
Blood creatinine increased (57)
Nausea (56)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which ENTRECTINIB Alternatives Have Lower Disease progression Risk?
ENTRECTINIB vs ENZALUTAMIDE
ENTRECTINIB vs EPCORITAMAB
ENTRECTINIB vs EPCORITAMAB-BYSP
ENTRECTINIB vs EPERISONE
ENTRECTINIB vs EPHEDRINE